Related Experiment Video
Updated: Aug 29, 2025

09:57
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
8.7K
Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study
Erlina Wijayanti1,2, Adang Bachtiar1, Anhari Achadi1
1Faculty of Public Health, Universitas Indonesia, Depok, Indonesia.
Plos One
|September 7, 2022
Summary
This study developed a mobile app to predict and improve medication safety for tuberculosis patients. The technology-driven approach aims to enhance treatment outcomes through better patient monitoring and education.
Area of Science:
- Public Health
- Digital Health
- Infectious Disease Management
Background:
- The COVID-19 pandemic accelerated technology adoption for patient monitoring.
- Improved management of tuberculosis (TB) patients is crucial for better treatment outcomes.
- Current TB patient management requires innovation, particularly in medication safety.
Purpose of the Study:
- To develop a predictive model for medication safety in TB patients.
- To create a solution model for at-risk TB patients using mobile applications.
- To enhance medication safety and patient monitoring through technological innovation.
Main Methods:
- A four-stage research design combining qualitative and quantitative methods (cross-sectional and quasi-experimental).
- Data collected from Public Health Centers in Jakarta, Indonesia, using cluster random sampling.
- Logistic regression analysis applied to quantitative data (n=114 and n=96) to identify predictors of medication safety.
Main Results:
- Identified key predictors of medication safety to aid in patient monitoring.
- Developed and utilized a mobile application with an algorithm for educating at-risk patients.
- The study provides a framework for technology-assisted TB patient management.
Conclusions:
- Mobile applications can significantly improve medication safety and patient monitoring for tuberculosis.
- Predictive modeling and targeted education are effective strategies for managing at-risk patients.
- Technological integration in healthcare offers promising solutions for infectious disease treatment adherence.
Related Concept Videos
Pulmonary Tuberculosis V
227
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
227
Pulmonary Tuberculosis IV
188
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
188
Pulmonary Tuberculosis I
302
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
302

